Biogen recruits Pfizer neuroscience star Michael Ehlers as new R&D chief

Michael Ehlers The bellwether biotech Biogen has wooed a top investigator from Pfizer to take over as head of R&D. The company reported this morning that Michael Ehlers, who had been running the neuroscience and pain research operations at Pfizer, is stepping into the role of executive vice president, R&D. Ehlers, a former Howard Hughes Medical Institute investigator at Duke, had specialized in neuronal organelles and the trafficking of neurotransmitter receptors. His background in the Cambridge/Boston hub working for Pfizer should prove to be a nice fit with Biogen, which has carved out an ambitious set of leading programs on Alzheimer’s and other tough diseases. Biogen’s former R&D chief, Doug Williams, left last summer to run a biotech startup. And Ehlers is benefiting once again from the migration of senior biotech…


Link to Full Article: Biogen recruits Pfizer neuroscience star Michael Ehlers as new R&D chief

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about homeAI.info and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!